The effects of reference pricing and other drug pricing policies

Morten Aaserud, Astrid A. Dahlgren, Jan Peter Kosters, Heidrun Strum, Craig R Ramsay, Andrew D. Oxman

Research output: Contribution to journalArticle

Abstract

We carried out a systematic review on studies of effects of pharmaceutical pricing policies. Ten studies of reference pricing and one study of index pricing were included. Based on the evidence in this review, mostly from senior citizens in British Columbia, Canada, reference drug pricing can reduce third party drug expenditures by inducing a shift in drug use towards less expensive drugs. We found no evidence of adverse effects on health and no clear evidence of increased health care utilisation.
Original languageEnglish
Pages (from-to)2-8
Number of pages7
JournalRegulatory Rapporteur
Volume3
Issue number10
Publication statusPublished - Oct 2006

Fingerprint

Costs and Cost Analysis
Pharmaceutical Preparations
Costs
Patient Acceptance of Health Care
British Columbia
Drug and Narcotic Control
Health Expenditures
Canada
Health care
Health

Keywords

  • pharmaceutical policies
  • drug pricing
  • reference pricing

Cite this

Aaserud, M., Dahlgren, A. A., Kosters, J. P., Strum, H., Ramsay, C. R., & Oxman, A. D. (2006). The effects of reference pricing and other drug pricing policies. Regulatory Rapporteur, 3(10), 2-8.

The effects of reference pricing and other drug pricing policies. / Aaserud, Morten; Dahlgren, Astrid A.; Kosters, Jan Peter; Strum, Heidrun; Ramsay, Craig R; Oxman, Andrew D.

In: Regulatory Rapporteur, Vol. 3, No. 10, 10.2006, p. 2-8.

Research output: Contribution to journalArticle

Aaserud, M, Dahlgren, AA, Kosters, JP, Strum, H, Ramsay, CR & Oxman, AD 2006, 'The effects of reference pricing and other drug pricing policies', Regulatory Rapporteur, vol. 3, no. 10, pp. 2-8.
Aaserud M, Dahlgren AA, Kosters JP, Strum H, Ramsay CR, Oxman AD. The effects of reference pricing and other drug pricing policies. Regulatory Rapporteur. 2006 Oct;3(10):2-8.
Aaserud, Morten ; Dahlgren, Astrid A. ; Kosters, Jan Peter ; Strum, Heidrun ; Ramsay, Craig R ; Oxman, Andrew D. / The effects of reference pricing and other drug pricing policies. In: Regulatory Rapporteur. 2006 ; Vol. 3, No. 10. pp. 2-8.
@article{707b5d64885e40c584c6df46a551fa64,
title = "The effects of reference pricing and other drug pricing policies",
abstract = "We carried out a systematic review on studies of effects of pharmaceutical pricing policies. Ten studies of reference pricing and one study of index pricing were included. Based on the evidence in this review, mostly from senior citizens in British Columbia, Canada, reference drug pricing can reduce third party drug expenditures by inducing a shift in drug use towards less expensive drugs. We found no evidence of adverse effects on health and no clear evidence of increased health care utilisation.",
keywords = "pharmaceutical policies, drug pricing, reference pricing",
author = "Morten Aaserud and Dahlgren, {Astrid A.} and Kosters, {Jan Peter} and Heidrun Strum and Ramsay, {Craig R} and Oxman, {Andrew D.}",
year = "2006",
month = "10",
language = "English",
volume = "3",
pages = "2--8",
journal = "Regulatory Rapporteur",
issn = "1742-8955",
publisher = "TOPRA",
number = "10",

}

TY - JOUR

T1 - The effects of reference pricing and other drug pricing policies

AU - Aaserud, Morten

AU - Dahlgren, Astrid A.

AU - Kosters, Jan Peter

AU - Strum, Heidrun

AU - Ramsay, Craig R

AU - Oxman, Andrew D.

PY - 2006/10

Y1 - 2006/10

N2 - We carried out a systematic review on studies of effects of pharmaceutical pricing policies. Ten studies of reference pricing and one study of index pricing were included. Based on the evidence in this review, mostly from senior citizens in British Columbia, Canada, reference drug pricing can reduce third party drug expenditures by inducing a shift in drug use towards less expensive drugs. We found no evidence of adverse effects on health and no clear evidence of increased health care utilisation.

AB - We carried out a systematic review on studies of effects of pharmaceutical pricing policies. Ten studies of reference pricing and one study of index pricing were included. Based on the evidence in this review, mostly from senior citizens in British Columbia, Canada, reference drug pricing can reduce third party drug expenditures by inducing a shift in drug use towards less expensive drugs. We found no evidence of adverse effects on health and no clear evidence of increased health care utilisation.

KW - pharmaceutical policies

KW - drug pricing

KW - reference pricing

M3 - Article

VL - 3

SP - 2

EP - 8

JO - Regulatory Rapporteur

JF - Regulatory Rapporteur

SN - 1742-8955

IS - 10

ER -